Martin P. Behe
Villigen, AG 5232, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2026
La-[18/19F]fluoride complexes: a novel addition to the radiofluorination family.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: March 30, 2026
The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study.
Journal: EJNMMI radiopharmacy and chemistry
Published: January 23, 2026
Advancing towards cancer theragnostic by probing the 225Ac decay chain with ultra-high-resolution metallic magnetic calorimeter based detectors.
Journal: Communications medicine
Published: July 12, 2025
The "Two-Step Boost" for [177Lu]Lu-PP-F11N Therapy: Optimization of Tumor Uptake by Premedication.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 11, 2025
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model.
Journal: Nuclear medicine and biology
Published: March 28, 2025
Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis.
Journal: International journal of molecular sciences
Published: March 21, 2025
161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 04, 2024
161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 24, 2024
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 17, 2024
Site-Specific Modification of Native IgGs with Flexible Drug-Load.
Journal: Chembiochem : a European journal of chemical biology
Published: June 12, 2024
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study.
Journal: EJNMMI research
Published: January 17, 2024
Last Updated: 09/26/2026